TY - JOUR
T1 - Advanced tools for tissue engineering
T2 - Scaffolds, bioreactors, and signaling
AU - Freed, Lisa E.
AU - Guilak, Farshid
AU - Guo, X. Edward
AU - Gray, Martha L.
AU - Tranquillo, Robert
AU - Holmes, Jeffrey W.
AU - Radisic, Milica
AU - Sefton, Michael V.
AU - Kaplan, David
AU - Vunjak-Novakovic, Gordana
PY - 2006/12
Y1 - 2006/12
N2 - This article contains the collective views expressed at the second session of the workshop "Tissue Engineering-The Next Generation," which was devoted to the tools of tissue engineering: scaffolds, bioreactors, and molecular and physical signaling. Lisa E. Freed and Farshid Guilak discussed the integrated use of scaffolds and bioreactors as tools to accelerate and control tissue regeneration, in the context of engineering mechanically functional cartilage and cardiac muscle. Edward Guo focused on the opportunities that tissue engineering generates for studies of mechanobiology and on the need for tissue engineers to learn about mechanical forces during tissue and organ genesis. Martha L. Gray focused on the potential of biomedical imaging for noninvasive monitoring of engineered tissues and on the opportunities biomedical imaging can generate for the development of new markers. Robert Tranquillo reviewed the approach to tissue engineering of a spectrum of avascular habitually loaded tissues-blood vessels, heart valves, ligaments, tendons, cartilage, and skin. Jeffrey W. Holmes offered the perspective of a "reverse paradigm"-the use of tissue constructs in quantitative studies of cell-matrix interactions, cell mechanics, matrix mechanics, and mechanobiology. Milica Radisic discussed biomimetic design of tissue-engineering systems, on the example of synchronously contractile cardiac muscle. Michael V. Sefton proposed a new, simple approach to the vascularization of engineered tissues. This session stressed the need for advanced scaffolds, bioreactors, and imaging technologies and offered many enlightening examples on how these advanced tools can be utilized for functional tissue engineering and basic research in medicine and biology.
AB - This article contains the collective views expressed at the second session of the workshop "Tissue Engineering-The Next Generation," which was devoted to the tools of tissue engineering: scaffolds, bioreactors, and molecular and physical signaling. Lisa E. Freed and Farshid Guilak discussed the integrated use of scaffolds and bioreactors as tools to accelerate and control tissue regeneration, in the context of engineering mechanically functional cartilage and cardiac muscle. Edward Guo focused on the opportunities that tissue engineering generates for studies of mechanobiology and on the need for tissue engineers to learn about mechanical forces during tissue and organ genesis. Martha L. Gray focused on the potential of biomedical imaging for noninvasive monitoring of engineered tissues and on the opportunities biomedical imaging can generate for the development of new markers. Robert Tranquillo reviewed the approach to tissue engineering of a spectrum of avascular habitually loaded tissues-blood vessels, heart valves, ligaments, tendons, cartilage, and skin. Jeffrey W. Holmes offered the perspective of a "reverse paradigm"-the use of tissue constructs in quantitative studies of cell-matrix interactions, cell mechanics, matrix mechanics, and mechanobiology. Milica Radisic discussed biomimetic design of tissue-engineering systems, on the example of synchronously contractile cardiac muscle. Michael V. Sefton proposed a new, simple approach to the vascularization of engineered tissues. This session stressed the need for advanced scaffolds, bioreactors, and imaging technologies and offered many enlightening examples on how these advanced tools can be utilized for functional tissue engineering and basic research in medicine and biology.
UR - http://www.scopus.com/inward/record.url?scp=33845918916&partnerID=8YFLogxK
U2 - 10.1089/ten.2006.12.3285
DO - 10.1089/ten.2006.12.3285
M3 - Article
C2 - 17518670
AN - SCOPUS:33845918916
SN - 1076-3279
VL - 12
SP - 3285
EP - 3305
JO - Tissue Engineering
JF - Tissue Engineering
IS - 12
ER -